Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL3425347 | 0.96 | TDP1 (0.33) | TDP1 | |
| SCHEMBL16307424 | 0.72 | — | — | |
| SCHEMBL5954330 | 0.62 | — | — | |
| SCHEMBL6854760 | 0.62 | — | — | |
| SCHEMBL15740350 | 0.62 | — | — | |
| SCHEMBL80808 | 0.55 | — | — | |
| SCHEMBL472031 | 0.53 | — | — | |
| SCHEMBL2020 | 0.53 | — | — | |
| SCHEMBL37550 | 0.53 | — | — | |
| SCHEMBL1332279 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1876181-B1 | IONIC LIQUID CONTAINING PHOSPHONIUM ION AND METHOD FOR PRODUCING SAME | KANTO DENKA KOGYO KK (JP) | 2013-07-24 | — | — | EP | disclosed |
| US-20090023954-A1 | Ionic liquid containing phosphonium ion and method for producing the same | KANTO DENKA KOGYO CO., LTD. (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1876181-A1 | IONIC LIQUID CONTAINING PHOSPHONIUM ION AND METHOD FOR PRODUCING SAME | Kanto Denka Kogyo CO., LTD. (JP) | 2008-01-09 | — | — | EP | disclosed |
| US-4317936-A | CATIONIC OR ANIONIC ION EXCHANGE RESINS MODIFIED BY A GROUP 8 METAL AND A HETRATOM-CONTAINING COMPOUND | SHELL OIL COMPANY (US) | 1982-03-02 | — | — | US | disclosed |
| US-4306085-A | Hydroformylation process using resin-ligand-metal catalyst | SHELL OIL COMPANY (US) | 1981-12-15 | — | — | US | disclosed |
| EP-0005569-B1 | RESIN-LIGAND-TRANSITION METAL COMPLEX COMPOSITION AND PROCESSES FOR USING THIS COMPOSITION AS CATALYST | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1981-11-04 | — | — | EP | disclosed |
| EP-0002557-B1 | RESIN-LIGAND TRANSITION METAL COMPLEX COMPOSITION AND PROCESSES FOR USING THIS COMPOSITION AS CATALYST | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1981-09-23 | — | — | EP | disclosed |
| US-4284835-A | METAL COMPLEX CATALYST BOUND TO RESIN | SHELL OIL COMPANY (US) | 1981-08-18 | — | — | US | disclosed |
| US-4266085-A | Olefin disproportionation process | SHELL OIL COMPANY (US) | 1981-05-05 | — | — | US | disclosed |
| US-4179402-A | Resin-metal-ligand composition | SHELL OIL COMPANY (US) | 1979-12-18 | — | — | US | disclosed |
| US-4179403-A | Resin-ligand-metal complex compositions | SHELL OIL COMPANY (US) | 1979-12-18 | — | — | US | disclosed |
| EP-0005569-A1 | Resin-ligand-transition metal complex composition and processes for using this composition as catalyst | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1979-11-28 | — | — | EP | disclosed |
| EP-0002557-A2 | Resin-ligand transition metal complex composition and processes for using this composition as catalyst | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1979-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023954-A1 | Ionic liquid containing phosphonium ion and method for producing the same | PHOSPHO1, INPPL1, PIP5K1C | TDP1 2011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.